C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2001
12/13/2001	WO2001045637A3 Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides
12/13/2001	WO2001044200A3 Selective neurokinin antagonists
12/13/2001	US20010051733 5-(pyrazol-4-yl)carbonylbenzo(b)thiophenes or thiopyrans and 5-carboxy intermediate; herbicide; can be used in paddyland; low dosage; non-phytotoxic to crops
12/13/2001	US20010051640 C7 carbamoyloxy substituted taxanes
12/13/2001	US20010051639 Exceptional utility as antitumor agents; bioavailability and nontoxic; oral administration; e.g., 10-propionyl-10-deacetyl Baccatin III; anticarcinogenic agents
12/13/2001	US20010051614 Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
12/13/2001	CA2409877A1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
12/12/2001	EP1162196A1 Fused-ring compounds and use thereof as drugs
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161237A1 Protease inhibitors
12/12/2001	EP1161233A2 Lxr modulators
12/12/2001	EP0983266B1 novel tetrahydroisoquinolin thiophenecarboximidamides
12/12/2001	EP0961774B1 Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
12/12/2001	EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001	EP0785787B1 Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus
12/12/2001	EP0723540B1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
12/12/2001	EP0723539B1 Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
12/12/2001	CN1326450A Hydroxyflavone derivatives as tau protein kinase inhibitors
12/12/2001	CN1326445A Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors
12/12/2001	CN1326441A 4-Aroyl-Piperidin-CCR-3 receptor antagonists III
12/12/2001	CN1326439A Phenyl-substituted cyclic enaminones
12/12/2001	CN1326114A Image element containing closed compounds for taking pictures
12/12/2001	CN1076021C L-2',3'-dideoxy nucleoside analogs as antihepatitis B (HBV) and anti-HIV agents
12/11/2001	US6329534 Useful for therapy of type ii diabetes, obesity, hyperglycemia, inadequate glucose clearance, hyperinsulinemia, hypertriglyceridemia, and high-circulating glucocorticoid levels
12/11/2001	US6329528 Reacting alkyl benzthioimidate or its acid addition salt with furan or thiofuran acid chloride compound to product adduct-intermediate; reacting with methylhydrazine to produce 3-(substituted phenyl)-5-thienyl or furyl)-1,2,4-triazoles
12/11/2001	US6329524 Cyclic sulfone containing retroviral protease inhibitors
12/11/2001	US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
12/11/2001	US6329418 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
12/11/2001	US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same
12/11/2001	US6329400 Formamide compounds as therapeutic agents
12/11/2001	US6329397 Hydroxy pipecolate hydroxamic acid derivatives
12/11/2001	US6329392 Substituted piperidines useful for the treatment of allergic diseases
12/11/2001	US6329389 Amine compounds, their production and use
12/11/2001	US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders
12/11/2001	US6329380 Pyrimidine benzimidizazole, pyrimidineimidazole or pyridine imidazole compounds for anticancer agents or atherosclerosis
12/11/2001	US6329372 Phenylalanine derivatives
12/11/2001	US6329369 Methods of treating pain and other conditions
12/06/2001	WO2001092229A1 TNF-α PRODUCTION INHIBITORS
12/06/2001	WO2001092227A1 Chemical compounds
12/06/2001	WO2001092226A1 Heterocyclic analgesic compounds and method of use thereof
12/06/2001	WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents
12/06/2001	WO2001091807A2 Ethylenedicysteine (ec)-drug conjugates
12/06/2001	WO2001049673A3 Compounds and methods for modulation of estrogen receptors
12/06/2001	WO2001046178A3 Substituierte bisindolymaleimide
12/06/2001	WO2001046165A3 N-heteroaryl-amides and their use as parasiticides
12/06/2001	WO2001029033A3 Thiono-thiochroman and -dihydrobenzothiophene compounds as herbicidal agents
12/06/2001	WO2001017999A3 Amino-triazolopyridine derivatives
12/06/2001	WO2001010847A8 Novel integrin receptor antagonists
12/06/2001	US20010049444 Pyridine-substituted benzanilides as potassium ion channel openers
12/06/2001	CA2736344A1 Tnf-.alpha. production inhibitors
12/06/2001	CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
12/05/2001	EP1160331A1 Enzymatic oxidations
12/05/2001	EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists
12/05/2001	EP1159278A2 Inhibitors of aspartyl protease
12/05/2001	EP1159269A1 Anti-imflammatory indole derivatives
12/05/2001	EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors
12/05/2001	EP1158986A1 Protease inhibitors
12/05/2001	EP1017690B1 Novel aromatic substituted naphthopyrans
12/05/2001	EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
12/05/2001	EP0821684B1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex
12/05/2001	EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/05/2001	EP0745071B1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
12/05/2001	CN1325384A Anthranilic acid amides and the use thereof as medicaments
12/04/2001	US6326495 Heating a mixture of caprolactone and p-methoxybenzylamine; cyclization
12/04/2001	US6326395 Amidine or amide substituted furan derivatives
12/04/2001	US6326385 Administering poltassium channel modulator
12/04/2001	US6326380 Thrombin receptor antagonists
12/04/2001	US6326333 Herbicides
11/2001
11/30/2001	CA2349057A1 Enzymatic oxidations
11/30/2001	CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	WO2001090097A2 Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
11/29/2001	WO2001090084A1 Benzodiazepine derivatives as app modulators
11/29/2001	WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001	WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001089457A2 Thrombopoietin mimetics
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	WO2001049674A3 Glycosidase inhibitors and preparation thereof
11/29/2001	WO2001034576A3 Use of pyrimidinone derivatives for controlling undesired microorganisms
11/29/2001	WO2001028996A3 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/29/2001	US20010047015 1H-1,2,4-Triazole derivative containing an aryl-substituted saturated 1,3-dioxane or 1,3-dioxepane ring
11/29/2001	US20010047008 Allosteric adenosine receptor modulators
11/29/2001	US20010047006 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
11/29/2001	US20010046989 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
11/29/2001	US20010046975 Fungicides for the control of take-all disease of plants
11/29/2001	US20010046676 Integrated sequencing device
11/29/2001	DE10123349A1 New N-sulfonylated pipecolic acid derivatives, are matrix metalloprotease inhibitors useful e.g. for treating rheumatism, tumor progression, arteriosclerosis or inflammatory bowel disease
11/29/2001	CA2412651A1 Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	CA2409998A1 Benzodiazepine derivatives as app modulators
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158358A2 Imaging element containing a blocked photographically useful compound
11/28/2001	EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157019A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
11/28/2001	EP1157009A1 Dopamine d1 receptor agonist compounds

1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 523